NCT01021241View on ClinicalTrials.gov

Safety and Efficacy Study of Intravenous Uricase-PEG 20

PHASE1UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
GoutHyperuricemia
Interventions
BIOLOGICAL

Uricase-PEG 20

Intravenous infusion of Uricase-PEG 20 over one hour; no premedication

Trial Locations (2)

16635

Altoona Center for Clinical Research, Duncansville

33143

MRA Clinical Research, Miami

Sponsors

Lead Sponsor

EnzymeRx
All Listed Sponsors
lead

EnzymeRx

INDUSTRY